Glenmark Pharmaceuticals reported a second-quarter profit on Thursday, helped by strong demand for its drugs that treat long-term illnesses. The drugmaker reported a consolidated profit of ...
EID Parry India Ltd.’s standalone net profit for the September quarter contracted 67% year-on-year to ₹28 crore. Revenue from operations registered a marginal growth of 4% growth at ₹755 crore, the ...